Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Jacob D Soumerai

1-22 of 22 results

View this query on the Wikidata Query Service
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.

scientific article
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs

scientific article published on 8 December 2008
Thalidomide and rituximab in Waldenstrom macroglobulinemia

scientific article
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

scientific article
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.

scientific article
Diagnosis and management of Castleman disease.

scientific article
Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease.

scientific article
Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia.

scientific article
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.

scientific article published on 23 January 2008
Long-term follow-up of symptomatic patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab

scientific article
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.

scientific article
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia

scientific article published on 3 June 2008
Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy

scientific article published on 01 March 2009
Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.

scientific article published in January 2007
Novel agents in the treatment of Waldenström's macroglobulinemia.

scientific article published on August 2007
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia

scientific article published on 06 February 2009
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma

scientific article
The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.

scientific article published on 15 July 2016
Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials

scientific article published on 08 November 2018
Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia

scientific article published on 10 May 2019
Case 7-2019: A 73-Year-Old Woman with Swelling of the Right Groin and Fever

scientific article published on 01 February 2019
Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma

scientific article published on 15 July 2020

Paulina is supported by:

About Paulina

Help